Triterpenoids from Ocimum labiatum activates latent HIV-1 expression in vitro : potential for use in adjuvant therapy

Loading...
Thumbnail Image

Authors

Kapewangolo, Petrina T.
Omolo, Justin J.
Fonteh, Pascaline Nanga
Kandawa-Schulz, Martha
Meyer, Debra

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI Publishing

Abstract

Latent HIV reservoirs in infected individuals prevent current treatment from eradicating infection. Treatment strategies against latency involve adjuvants for viral reactivation which exposes viral particles to antiretroviral drugs. In this study, the effect of novel triterpenoids isolated from Ocimum labiatum on HIV-1 expression was measured through HIV-1 p24 antigen capture in the U1 latency model of HIV-1 infection and in peripheral blood mononuclear cells (PBMCs) of infected patients on combination antiretroviral therapy (cART). The mechanism of viral reactivation was determined through the compound’s effect on cytokine production, histone deacetylase (HDAC) inhibition, and protein kinase C (PKC) activation. Cytotoxicity of the triterpenoids was determined using a tetrazolium dye and flow cytometry. The isolated triterpene isomers, 3-hydroxy-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-octadecahydrop icene-4,8a-dicarboxylic acid (HHODC), significantly (p < 0.05) induced HIV-1 expression in a dose-dependent manner in U1 cells at non-cytotoxic concentrations. HHODC also induced viral expression in PBMCs of HIV-1 infected patients on cART. In addition, the compound up-regulated the production of interleukin (IL)-2, IL-6, tumour necrosis factor (TNF)- , and interferon (IFN)- but had no effect on HDAC and PKC activity, suggesting cytokine upregulation as being involved in latency activation. The observed in vitro reactivation of HIV-1 introduces the adjuvant potential of HHODC for the first time here.

Description

Supplementary Material: Figure S1: Effect of amyrin on HIV-1 expression, Figure S2: Effect of HHODC on HIV-1 PR, Figure S3a,b: Effects of HHODC on HDAC and PKC activities, Figure S4: Effect of HHODC on the viability of PBMCs.

Keywords

Ocimum labiatum, Novel triterpenoids, Latent HIV-1, HIV-1 eradication, Cytokines, Human immunodeficiency virus (HIV), Peripheral blood mononuclear cell (PBMC), Histone deacetylase (HDAC), Protein kinase C (PKC)

Sustainable Development Goals

Citation

Kapewangolo, P., Omolo, J.J., Fonteh, P., Kandawa-Schulz, M. & Meyer, D. 2017, 'Triterpenoids from Ocimum labiatum activates latent HIV-1 expression in vitro : potential for use in adjuvant therapy', Molecules, vol. 22, art. no. 1703, pp. 1-14.